Braun Gerald S, Veh Rüdiger W, Segerer Stephan, Horster Michael F, Huber Stephan M
Physiologisches Institut, Ludwig-Maximilians-Universität, 80336 Munich, Germany.
Pflugers Arch. 2002 Dec;445(3):321-30. doi: 10.1007/s00424-002-0906-x. Epub 2002 Nov 6.
Kir channel subunit expression during development of the rat collecting-duct epithelium was quantified by RT-PCR of primary monolayer cultures. mRNAs of the vascular-type K(ATP) (K(NDP)) channel-forming subunits Kir6.1/SUR2 were highly expressed in early ureteric bud generations (embryonic day E14) and downregulated thereafter, while Kir1.1b (ROMK2) mRNA increased fourfold during cortical collecting duct (CCD) maturation. As assessed by immunohistochemistry, Kir6.1 protein was abundant in the apical and basolateral plasma membranes of early ureteric buds and trunks (E15 to postnatal day P1), downregulated thereafter and not detectable in CCD and outer medullary collecting ducts (OMCD) (P7). During nephron development, Kir6.1 protein was expressed ubiquitously on plasma membranes of early nephron stages from mesenchymal condensations to S-shaped bodies. After fusion of nephron and CCD, Kir6.1 protein was restricted to the apical membrane of proximal tubule. The Kir6/SUR2 channel opener, pinacidil (100 microM/2 days), increased tubulogenesis in organ culture by a factor of 3. Cell proliferation of human embryonic kidney cells (HEK 293) which endogenously express Kir6.1/SUR2 mRNA was stimulated by pinacidil in a dose-dependent manner, an effect that was partially abolished by glibenclamide (3 microM). In summary, Kir6.1/SUR2 channel subunits are highly expressed during early development of ureteric bud and nephron epithelia where Kir6.1/SUR2 activity regulates cell proliferation.
通过对原代单层培养物进行逆转录聚合酶链反应(RT-PCR),对大鼠集合管上皮发育过程中钾离子通道亚基的表达进行了定量分析。血管型ATP敏感性钾通道(K(ATP),即K(NDP))形成亚基Kir6.1/SUR2的信使核糖核酸(mRNAs)在输尿管芽早期(胚胎第14天,E14)高度表达,此后表达下调,而Kir1.1b(ROMK2)信使核糖核酸在皮质集合管(CCD)成熟过程中增加了四倍。免疫组织化学评估显示,Kir6.1蛋白在输尿管芽早期和输尿管干(E15至出生后第P1天)的顶端和基底外侧质膜中丰富,此后表达下调,在CCD和外髓集合管(OMCD)(P7)中检测不到。在肾单位发育过程中,从间充质凝聚到S形小体的早期肾单位阶段,Kir6.1蛋白在质膜上普遍表达。肾单位与CCD融合后,Kir6.1蛋白局限于近端小管的顶端膜。Kir6/SUR2通道开放剂吡那地尔(100微摩尔/2天)使器官培养中的肾小管形成增加了3倍。内源性表达Kir6.1/SUR2信使核糖核酸的人胚肾细胞(HEK 293)的细胞增殖受到吡那地尔的剂量依赖性刺激,格列本脲(3微摩尔)可部分消除这种作用。总之,Kir6.1/SUR2通道亚基在输尿管芽和肾单位上皮的早期发育过程中高度表达,其中Kir6.1/SUR2活性调节细胞增殖。